Harbin Pharmaceutical Group's low P/S ratio may indicate ant...

Harbin Pharmaceutical Group's low P/S ratio may indicate anticipated poor growth or falling revenue, underperforming the industry. The company's recent revenue trends, worse than industry expectations, contribute to its low P/S. Shareholders accept this, expecting no future revenue surprises. Unless medium-term conditions improve, they will continue to hinder the share price.